Aditxt (NASDAQ:ADTX) Posts Earnings Results

Aditxt (NASDAQ:ADTX) announced its quarterly earnings results on Wednesday. The company reported $999.00 earnings per share (EPS) for the quarter, Zacks reports. Aditxt had a negative net margin of 1,217,927.00% and a negative return on equity of 374.60%.

Aditxt Price Performance

Shares of ADTX stock traded down $0.12 during trading hours on Wednesday, hitting $1.40. 214,893 shares of the company’s stock were exchanged, compared to its average volume of 77,335. The stock’s 50-day moving average is $20.45 and its 200-day moving average is $285.05. The stock has a market cap of $46,200.00, a price-to-earnings ratio of 0.00 and a beta of 1.08. Aditxt has a 52 week low of $1.34 and a 52 week high of $53,451.08.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aditxt in a report on Monday, April 20th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company has a consensus rating of “Sell”.

About Aditxt

Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.

The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.